MGX · Metagenomi Therapeutics, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-09 | Reid Laurence |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
17,400 |
| 2026-06-09 | BJERKHOLT ERIC |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
21,000 |
| 2026-06-09 | Eckhardt Juergen |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
21,000 |
| 2026-06-09 | Dere Willard H |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
21,000 |
| 2026-06-05 | Wapnick Pamela |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
2,884 |
| 2026-06-05 | Wein Matthew |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person. Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026. |
Common Stock
|
558 |
| 2026-06-05 | Irish Jian |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person. Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026. |
Common Stock
|
3,737 |
| 2026-04-01 | Wapnick Pamela |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
144,000 |
| 2026-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
11,000 |
| 2026-04-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
46,000 |
| 2026-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
68,000 |
| 2026-04-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
276,000 |
| 2026-04-01 | Wapnick Pamela |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
24,000 |
| 2026-03-05 | Wapnick Pamela |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
1,581 |
| 2026-03-05 | Wein Matthew |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
482 |
| 2026-03-05 | Irish Jian |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
1,607 |
| 2025-12-05 | Wein Matthew |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
199 |
| 2025-12-05 | Irish Jian |
Director, See Remarks |
Gift↓
Filing footnotes — Common Stock (Direct)
On December 5, 2025, the Reporting Person transferred 114,231 and 114,231 shares of Issuer common stock to the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish and Jian Irish 2023 Irrevocable Trust, respectively, for no consideration. |
Common Stock
|
228,462 |
| 2025-12-05 | Irish Jian |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
1,602 |
| 2025-12-05 | Wapnick Pamela |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
1,576 |
| 2025-12-05 | Thomas Brian C. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
3,830 |
| 2025-12-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
96,000 |
| 2025-12-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent RSUs. 25% of the RSUs shall vest on December 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
37,500 |
| 2025-12-01 | Wapnick Pamela |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
120,000 |
| 2025-12-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
211,000 |
| 2025-12-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on November 6, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
225,000 |
| 2025-09-05 | Wein Matthew |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. Includes 1,359 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 30, 2025 and 1,377 shares acquired under the Company's ESPP on November 28, 2025. |
Common Stock
|
199 |
| 2025-09-05 | Wapnick Pamela |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
1,576 |
| 2025-09-05 | Thomas Brian C. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. |
Common Stock
|
2,701 |
| 2025-09-05 | Irish Jian |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person. Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 30, 2025 and 1,500 shares acquired under the Company's ESPP on November 28, 2025. |
Common Stock
|
1,602 |
| 2025-09-02 | Reid Laurence |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
33% of the shares subject to this option shall vest and become exercisable on September 2, 2026, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
42,000 |
| 2025-08-11 | Reid Laurence |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-06-10 | Eckhardt Juergen |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
21,000 |
| 2025-06-10 | BJERKHOLT ERIC |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
8,572 |
| 2025-06-10 | Dere Willard H |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date. |
Stock Option (Right to Buy)
|
21,000 |
| 2025-06-06 | Wapnick Pamela |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person. |
Common Stock
|
1,576 |
| 2025-06-06 | Wein Matthew |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person. |
Common Stock
|
199 |
| 2025-06-06 | Noonberg Sarah B. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person. |
Common Stock
|
5,239 |
| 2025-06-06 | Thomas Brian C. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person. |
Common Stock
|
10,785 |
| 2025-06-06 | Irish Jian |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person. |
Common Stock
|
6,390 |
| 2025-04-01 | Irish Jian |
Director, See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
23,000 |
| 2025-04-01 | Thomas Brian C. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
32,000 |
| 2025-04-01 | Noonberg Sarah B. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
84,000 |
| 2025-04-01 | Thomas Brian C. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
196,000 |
| 2025-04-01 | Noonberg Sarah B. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
14,000 |
| 2025-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on March 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
3,775 |
| 2025-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Common Stock
|
3,650 |
| 2025-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
22,725 |
| 2025-04-01 | Wapnick Pamela |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
84,000 |
| 2025-04-01 | Wein Matthew |
See Remarks |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
21,875 |